Preemptive versus prophylactic therapy using valganciclovir or ganciclovir in renal transplant recipients for the prevention of cytomegalovirus infection: a systematic review and meta-analysis
Clinical Transplantation and Research · 2023
DOI: 10.4285/atw2023.f-8170 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Transplantation and Research, 2023. Verfasst von Michelle Wendy Te und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Kidney transplant recipients are at risk for developing cytomegalovirus (CMV) disease and subsequently, allograft rejection and graft loss. The current practice of prophylaxis with antiviral therapy in the early posttransplant period for high risk patients is costly. Preemptive therapy involves a protocol of routine testing for CMV viral load, and treatment is initiated for positive patients. It is unknown if preemptive therapy is an effective strategy to prevent CMV disease. This study aims to assess the efficacy of preemptive versus prophylactic therapy with valganciclovir or ganciclovir in preventing CMV disease in kidney transplant recipients.
Methods
A comprehensive search of PubMed/Medline, Cochrane, and Google scholar was performed to identify clinical trials on the efficacy of preemptive versus prophylactic valganciclovir or ganciclovir in preventing CMV disease. The primary outcome is development of CMV infection. Secondary outcomes include acute allograft rejection, allograft loss, and mortality.
Zitieren
APA
Te, M. W., Boado, C., Vergara-Rejante, L., & Suarez, E. E. (2023). Preemptive versus prophylactic therapy using valganciclovir or ganciclovir in renal transplant recipients for the prevention of cytomegalovirus infection: a systematic review and meta-analysis. Clinical Transplantation and Research. https://doi.org/10.4285/atw2023.f-8170
Vancouver
Te MW, Boado C, Vergara-Rejante L, Suarez EE. Preemptive versus prophylactic therapy using valganciclovir or ganciclovir in renal transplant recipients for the prevention of cytomegalovirus infection: a systematic review and meta-analysis. Clinical Transplantation and Research. 2023. doi:10.4285/atw2023.f-8170
BibTeX
@article{Te2023,
author = {Te, Michelle Wendy and Boado, Carlo and Vergara-Rejante, Larraine and Suarez, Ethan Elijah},
title = {Preemptive versus prophylactic therapy using valganciclovir or ganciclovir in renal transplant recipients for the prevention of cytomegalovirus infection: a systematic review and meta-analysis},
journal = {Clinical Transplantation and Research},
year = {2023},
doi = {10.4285/atw2023.f-8170}
}
EUVIMED